MedTrace Logo

Cornea Ectasia Excimer Laser Treatment

NCT04405882 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2020-05-28

No results posted yet for this study

Summary

To evaluate efficacy, safety, objective and subjective quality of vision after treatment of cornea ectasia with transepithelial topographic guided laser simultaneous Central Corneal Remodeling (CCR) and Cross-linking (CXL).

Conditions

  • Corneal Ectasia

Interventions

PROCEDURE

topographic guided trans epithelial excimer laser

In this retrospective study 8 eyes affected by cornea ectasia of 8 patients (mean age 31.50±14.73 years) underwent simultaneous CCR and CXL. Preoperative and 6 month postoperative uncorrected distance visual acuity (UDVC) and distance corrected visual acuity (DCVA) were measured using the Efficacy and Safety index. Objective and subjective quality of vision were respectively evaluated through preoperative and 6 month postoperative corneal morphological irregularity index (CMI), National Eye Institute Visual Function NEI-VFQ25 and NEI-VFQ39 questionnaires.

Sponsors & Collaborators

  • Bambino Gesù Hospital and Research Institute

    lead OTHER

Eligibility

Min Age
19 Years
Max Age
66 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2019-10-31
Completion
2020-04-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04405882 on ClinicalTrials.gov